Delivery Order SPE2DB22D1017-SPE2DB25FG2NK
Award Date
5/13/25
Potential Completion Date
5/14/25
Potential Value
$1.2K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp is a delivery order from the Defense Logistics Agency (DLA) worth $34,097.96. The contract is for the supply of CELLCEPT 500 MG TABLET 100S, a pharmaceutical product, with a completion date of May 9, 2025. The contract has a firm fixed price pricing type and is not set aside. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that holds a significant Indefinite Delivery Contract (IDC) with...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $35,651.91 firm-fixed-price delivery order contract is for the supply of 4,568,039,684 units of CELLCEPT 500 MG TABLET 500S, a medication used for organ transplant patients. The contract has an ultimate completion date of April 28, 2025. Amerisourcebergen Drug Corp holds a substantial $999,999,999.00 Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $16,147.27 firm fixed-price delivery order is for the supply of CELLCEPT 500 MG TABLET 500S, a pharmaceutical product. This award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $15,805.39 firm fixed-price delivery order contract is for the supply of CELLCEPT 500 MG TABLET 100S to support federal healthcare programs. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for providing a comprehensive...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $12,984.72 firm fixed-price contract is for the supply of CELLCEPT 500 MG TABLET 100S to support military healthcare programs. The contract has an ultimate completion date of January 7, 2025. The award is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical,...
This federal contract award is for the delivery of CellCept 500 mg tablets to the Defense Logistics Agency (DLA) Troop Support Medical. The $16,742.95 firm fixed price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA valued up to $999,999,999.00 through December 2025, which serves as the primary vehicle for the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,031.00 firm fixed price delivery order is for the supply of CELLCEPT 500 MG TABLET 100S, a medication used in the management of certain medical conditions. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $6,977.64 firm fixed price delivery order is for the supply of 4,564,932,585 units of CellCept 500 mg tablets. The contract has no set-aside designation and is part of a larger single-award Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. This IDC...
This federal contract award is a delivery order valued at $9,223.56, issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of CellCept 500 mg tablets, a brand name pharmaceutical product. The contract has a firm fixed price pricing type and a completion date of February 13, 2024. Amerisourcebergen Drug Corp is the prime contractor on this award, which is part of a larger indefinite delivery...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $85,073.04, is for the delivery of CELLCEPT 500 MG TABLET 500S, a pharmaceutical product, with a performance period through May 1, 2025. The contract is not set aside for any specific business type. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with...